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Abstract Mucolipidosis type II a/b is a severe, autosomal
recessive lysosomal storage disorder, caused by a defect in
the GNPTAB gene that codes for the a/b subunits of the
GlcNAc-phosphotransferase. To date, over 100 different
mutations have been identified in MLII a/b patients, but no
large deletions have been reported. Here we present the first
case of a large homozygous intragenic GNPTAB gene
deletion (c.3435-386_3602 + 343del897) encompassing
exon 19, identified in a ML II a/b patient. Long-range
PCR and sequencing methodologies were used to refine the
characterization of this rearrangement, leading to the
identification of a 21 bp repetitive motif in introns 18 and
19. Further analysis revealed that both the 50 and 30
breakpoints were located within highly homologous Alu
elements (Alu-Sz in intron 18 and Alu-Sq2, in intron 19),
suggesting that this deletion has probably resulted from
Alu–Alu unequal homologous recombination. RT-PCR
methods were used to further evaluate the consequences
of the alteration for the processing of the mutant pre mRNA
GNPTAB, revealing the production of three abnormal
transcripts: one without exon 19 (p.Lys1146_Trp1201del);
another with an additional loss of exon 20 (p.Arg1145-
Serfs*2), and a third in which exon 19 was substituted by a
pseudoexon inclusion consisting of a 62 bp fragment from
intron 18 (p.Arg1145Serfs*16). Interestingly, this 62 bp
fragment corresponds to the Alu-Sz element integrated in
intron 18.
This represents the first description of a large deletion
identified in the GNPTAB gene and contributes to enrich the
knowledge on the molecular mechanisms underlying
causative mutations in ML II.
Introduction
Mucolipidosis II a/b (ML II; MIM# 252500), ML III a/b
(MIM# 252600) and ML III g (MIM# 252605) are rare
lysosomal storage diseases which share similar clinical
features, including skeletal abnormalities. Among them,
mucolipidosis type II a/b is clinically the most severe. The
skeletal system is profoundly affected in all patients, who
usually present with abnormalities in both cartilage and
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bone. Linear growth decelerates during the first year of life
and almost ceases during the second year. Death usually
occurs between 5 and 8 years of age (Kornfeld and Sly
2001), although early death in utero as well as in the first
years of life is not uncommon.
The diseases are caused by deficiencies in activity of the
uridine diphosphate (UDP)-N-acetylglucosamine:lysosomal
enzyme N-acetylglucosamine-1-phosphotransferase
(GlcNAc-phosphotransferase), which may be reduced or
absent. GlcNAc-phosphotransferase is a multimeric enzyme
encoded by two genes: GNPTAB (a/b subunits) and
GNPTG (g subunit). Mutations in the GNPTAB gene are
associated with ML II a/b and ML III a/b, whereas those in
the GNPTG gene cause ML III g (Raas-Rothschild et al.
2000; Tiede et al. 2004).
The GNPTAB gene (GenBank accession number:
NG_021243.1), which codes for the a and b subunits,
contains 21 exons and spans 85 kb on chromosome
12q23.3. It encodes a protein of 1,256 amino acids with a
predicted molecular mass of 144 kDa (a/b precursor).
Proteolytic processing of the a/b precursor generates the
individual a and b subunits (Tiede et al. 2004).
To date, more than 100 different ML II a/b and ML III
a/b disease-causing mutations have been identified, includ-
ing 30 missense, 20 nonsense, 32 small deletions, 25 small
insertions, 2 small indels, and 14 splice site mutations
(Human Gene Mutation Database website [HGMD, http://
www.hgmd.org] and references therein). Large genomic
rearrangements were rarely reported (1.6%) including an
Alu retrotransposition in GNPTAB exon 5 (Tappino et al.
2008) and the exon 2 duplication (Otomo et al. 2009),
resulting from recombination between homologous regions
of introns 1 and 2.
In this work, we report on a large deletion found in the
GNPTAB gene. After performing a fine molecular screening
in an ML II a/b patient, we found a homozygous genomic
lesion in GNPTAB leading to the entire loss of exon 19 and
some of its surrounding intronic regions (c.3435-
386_3602 + 343del897). Analysis of the deletion break-
points indicated that the mutation may have been generated
by an unequal homologous recombination process between
highly similar Alu elements located in two out of three
regions within the gene where such kind of sequences were
demonstrated to be present. Subsequent cDNA analysis
revealed the presence of three abnormal transcripts created
by this gross deletion at mRNA level: one without exon 19
(p.Lys1146_Trp1201del); another with an additional loss of
exon 20 (p.Arg1145Serfs*2), and a third in which exon 19
was substituted by a pseudoexon inclusion consisting of a
62 bp fragment from intron 18 (p.Arg1145Serfs*16).
To the best of our knowledge, this represents the first
description of a large deletion identified in the GNPTAB
gene. Furthermore, the work adds on the knowledge of the
molecular mechanisms underlying causative mutations in
ML II, contributing to improved genetic counselling and
prenatal diagnosis in this devastating disease.
Material and Methods
Case Description
This boy was born at 38 weeks of gestation after a
caesarean section. His parents were healthy, consanguine-
ous Palestinians who also had a healthy 3-year-old son.
Birth weight was 2,085 g, length 42 cm and head
circumference 32 cm. Apgar scores were 9/1 and 10/5, but
shortly after birth he developed signs of respiratory insuffi-
ciency with oxygen saturation at 70% and was treated with
continuous positive airway pressure (CPAP) and oxygen.
At ultrasonography during pregnancy, the foetus was
noted to have short extremities, and at birth the newborn
presented with short, slightly bowed arms, and legs and
a large, protruding abdomen as well as mandibular hypo-
plasia and gingival hyperplasia. Bilateral inguinal hernia
developed at one month of age.
Initial investigations showed low phosphate at 0.8 mmol/L
(reference values: 1, 4–2, 3 mmol/L), increased alkaline
phosphatase at 1,518 U/L (reference values: 55–515 U/L)
increasing to 1,967 U/L at age 18 days. Parathyroid hormone
(PTH) was very high at 91, 2 pmol/L (reference values:
1, 1–6, 9 pmol/L). Calcium was initially slightly low, but
normalised quickly without treatment. 25-hydroxy-vitamin
D2 + D3 was below detection and investigations in his
mother also disclosed low 25-hydroxy-vitamin D2 + D3
< 10. Thus, the initial suspicion was that the child had
a severe congenital rachitis or hyperparathyroidism and
X-rays were thought compatible with that (Fig. 1).
Measurement of lysosomal enzymes revealed grossly
elevated hexosaminidase A and B activities in plasma,
consistent with mucolipidosis type II.
The child continued to have respiratory problems and
died in respiratory insufficiency at the age of 2 months.
Mutation Screening of GNPTAB from a gDNA Sample
Genomic DNA was isolated from fibroblasts according to
standard procedures. PCR amplifications of the 21 exons
and adjacent intronic regions of GNPTAB gene were
performed using specific primers (available on request).
PCR amplification was carried out using approximately
40 ng of genomic DNA, 1  PCR reaction mix ImmoMix
Red (Bioline, London, UK) and 0.25 mM of each primer.
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Thereafter, samples were heated to 95C for 7 min,
followed by 35 cycles of denaturation (30 s at 94C),
annealing (30 s at 58C to exons 2, 3, 4, 6, 11, 12, 14, 15,
16, 17, 18, 20, and 21; 30 s at 59C to exon 13; 30 s at
60C to exons 1, 5, 7, 8–10, and 19) and extension (45 s
at 72C). The final extension was completed by 7 min
at 72C.
Fragments were purified with ExoSap-IT (GE Health-
care, United Kingdom) according to the manufacturer’s
instructions and sequenced using a BigDye Terminator
Cycle Sequencing Kit (Applied Biosystems, Foster City,
CA, USA) on an ABI PRISM 3130xl Genetic Analyser
(Applied Biosystems, Foster City, CA, USA). Results were
analysed with the sequence analysis software FINCH TV
(Geospiza, Seattle, WA, USA) version 1.3.1.
Long-Range PCR and Characterization of Deletion
Breakpoints
Genomic GNPTAB was submitted to long-range PCR using
the following primers: primer forward (50–TGGAT-
GTTGAGTCCACTACGG–30), designed to anneal across
intron 17 and primer reverse (50–TCATTTTCTAAAA-
CATTCAGATGC–30), that anneals at intron 20 (see
Table 1). PCR mixture contained 500 ng of genomic
DNA, 1X PCR 3.75 U Expand Long Taq-System (Roche),
reaction buffer 3, 350 mM of each dNTP and 3 mM of each
primer. Thereafter, the samples were heated to 94C for
2 min, followed by 30 cycles of denaturation (10 s at 94C),
annealing (30 s at 58C) and extension (6 min at 68C).
In the last 20 cycles, the extension time had an increment of
20 s in each one. The final extension was completed by
7 min at 68C.
The long-range PCR fragment was purified with
ExoSap-IT (GE Healthcare, United Kingdom) and
sequenced. In order to detect the deletion breakpoints,
several internal primers were designed to sequence introns
18 and 19 (see Table 1).
cDNA Analysis
GNPTAB cDNA analysis was performed with specific
primers (see Table 1) according to the previously reported
conditions (Encarnação et al. 2009).
Bioinformatic Analysis
Considering that several genomic rearrangements are
frequently caused by recombination events promoted by
repetitive elements present in the human genome, the DNA
sequences flanking the 50 and 30 deletion breakpoints were
screened for the presence of such elements with the
RepeatMasker software (http://repeatmasker.org).
The scores for the splice site junctions were obtained
with the Maxent programme (http://genes.mit.edu/burgelab/
maxent/Xmaxentscanscoreseqacc.html) (Yeo and Burge
2004). Ideal Maxent splice site scores are: 11.81 (50ss)
and 13.59 (30ss).
Mutation Nomenclature
As reference for the GNPTAB gene, we used the sequence
available at http://www.ncbi.nlm.nih.gov/nuccore/
NG_021243 . 1 (GenBank a c c e s s i o n numbe r :
NG_021243.1).
As reference for the GNPTAB mRNA, we used the
sequence available at http://www.ncbi.nlm.nih.gov/nuccore/
NM_024312 . 4 (GenBank a cc e s s i on numbe r :
NM_024312.4).
Fig. 1 X-rays of left arm (a) and left leg (b) at birth. In both X-rays, shortening of bones, osteopenia, and a bone-in-bone appearance
are seen. The metaphyses are expanded with cupping and fraying
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Results and Discussion
The molecular examination of a ML II patient was initially
assessed through routine procedures, which involved
amplification and direct sequencing of GNPTAB exons
and flanking intronic regions (Encarnação et al. 2009).
However, the failure to amplify the fragment correspondent
to exon 19 and its intronic boundaries from the patient’s
DNA in face of normal amplification from control DNA,
led us to suspect that a large deletion could underlie the
molecular defect. To exclude that the nonamplification of
the fragment containing exon 19 was due to any polymor-
phic variation in the primer’s annealing region, a second
pair of primers was used that again resulted in unsuccessful
amplification of exon 19 (see primer sequences in Table 1).
No mutations were found in the remaining regions sequenced.
To investigate whether a large deletion was indeed
involved, a long-range PCR was designed to amplify
GNPTAB genomic DNA encompassing exons 18–20 and
respective intronic flanking sequences. This approach
resulted in amplification of different-sized fragments in
the patient and controls. The electrophoretic pattern in 2%
agarose gel of the long-PCR products clearly indicated that
the amplified fragment in the patient was shorter (approxi-
mately 7,000 bp) than the expected size (8,392 bp) of the
control (data not shown). To detect the deletion junction
region and disclose the exact size of the gene loss, four
internal primers annealing in intron 18 and another four
annealing in intron 19 were used for optimal sequencing of
the amplicon obtained through long-range PCR (Table 1).
The sequencing results allowed the identification of the
deletion breakpoints and the determination of the deletion
Table 1 Complete list of primers used to perform this work
gDNA amplification of exon 19 and its intronic boundaries
Localization Sequence Annealing
temperature
PCR product size Reference
Forward Intron 18 50-CCCATAGCTAAAAGGCCATCTACC-30 60C 436 bp Encarnação
et al. (2009)
Reverse Intron 19 50-GTATACACTCACCCACACACATGC-30 Encarnação
et al. (2009)
Forward 2 Intron 18 50-TTTGGAATCCACATCCTTGTT-30 60C 391 bp This study
Reverse 2 Intron 19 50-TGGGCAACAAGAACAAAACTC-30 This study
gDNA long range PCR
Localization Sequence Annealing
temperature
PCR product size Reference
Forward Intron 17 50–TGGATGTTGAGTCCACTACGG–30 58C 8,392 bp This study
Reverse Intron 20 50–TCATTTTCTAAAACATTCAGATGC–30 This study
Optimised sequencing of the long range amplicon
Localization Sequence Annealing
temperature
PCR product size Reference
Forward 1 Intron 18 50–TGGGCTCAAGCAATCCTCC–30 Not applicable This study
Forward 2 Intron 18 50–CCAGGTTTAGAGAAAGATGAA–30 This study
Forward 3 Intron 18 50–TTTTGGCGAATCTACTTCAAAAG–30 Not applicable This study
Forward 4 Intron 18 50–CCACATCTGGCTAATTTTCATA–30 This study
Reverse 1 Intron 19 50–AGGCGAGAGGGTATGAACTG–30 Not applicable This study
Reverse 2 Intron 19 50–TAGCAGCAATATTCATCCTAAT–30 This study
Reverse 3 Intron 19 50–CAATATTGCTAGTGATTATTCCCACA–30 Not applicable This study
Reverse 4 Intron 19 50–CAGTTGAATAAATGAAGTTCC–30 This study
cDNA amplification of a fragment ranging from exons 17–21
Localization Sequence Annealing
temperature
PCR product size Reference
Forward Exon 17 50-CCAGTAACTGACAAAATCCA-30 55C 734 bp Encarnação
et al. (2009)
Reverse Exon 21 50-ACAGGTCCATGAGCAAATTC-30 Encarnação
et al. (2009)
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extension which was 897 bp and included the last 386
nucleotides of intron 18, exon 19 (168 bp), and the first
343 bp of intron 19 (c.3435-386_3602 + 343del897).
Furthermore, we verified that a 21 bp perfect sequence
overlap (“aactcctgacctcaggtgatc”; Fig. 2a, b) occurred at the
two deletion breakpoints: the same sequence stretch was
present in intron 18 and intron 19. Additional sequence
analysis revealed that, in both introns, the “aactcctgacct-
caggtgatc” motif was flanked by highly homologous
sequences (Fig. 2b). The sequence alignment of the
genomic regions (introns 18 and 19), surrounding the
21 bp overlapping segment, showed high homology: in
particular, the 149 nucleotides upstream and the 59
nucleotides downstream of the deletion breakpoints shared
76.5% and 89.8% homology, respectively. Since this high
level of sequence homology suggested the presence of Alu
elements, both full-length intron sequences were submitted
to analysis by the Repeat Masker Web Server to search for
interspersed repeat elements. The “in silico” analysis
revealed that two next Alu sequences (Alu-Sz followed by
Alu-Sx) were present in intron 18 and another (Alu Sq2) in
intron 19. It was therefore evident that both the 50 and 30
breakpoints of the deletion were located within highly
homologous Alu elements (Fig. 2c). Additionally, when the
“in silico” analysis was extended to the entire gene, we
observed that the 30UTR region not only was highly
homology to introns 18 and 19 but also showed an Alu
element (Alu-Sx family) bearing the motif “aactcctgacct-
caggtgatc” (data not shown).
Alu elements are short interspersed elements (SINEs),
normally located within introns, and 30 untranslated regions
of genes, which are considered mutational “hotspots” for
large gene rearrangements.
Thus, it is highly probable that the mutation here
detected has arisen after an Alu–Alu unequal recombination
event. During DNA replication, the primer and template
strands might have transiently dissociated and then reasso-
ciated in a misaligned configuration mediated by the
Intron 18 breakpoint overlap Intron 19
Alu-Sz Alu-Sx Alu-Sq2
Alu-Sq2Alu-Sz Alu-Sx
Ex 18 Ex 19 Ex 20
Ex 18 Ex 20
897 bp
a
b
c
aactcctgacctcaggtgatc
Fig. 2 Characterization of the deletion breakpoints. (a) Electrophero-
gram evidencing the junction fragment resulting from the large deletion
in the affected individual. Partial representation of introns 18 and 19
with the 21 bp breakpoint overlap highlighted in pink. (b) Nucleotide
sequence alignment of the genomic sequence from introns 18 and 19 of
the GNPTAB gene. Sequence gaps are indicated by dashed lines, short
vertical lines indicate matched bases between both introns. Sequence
highlighted in aquamarine corresponds to the Alu-Sz element of intron
18; sequence highlighted in grey corresponds to the Alu-Sx element of
the same intron and, finally, the one highlighted in light violet, indicates
the Alu-Sq2 element of intron 19. (c) Schematic representation of the
deletion breakpoints and their flanking Alu elements. C1 represents
a normal gDNA fragment and C2 schematizes the mutated gDNAwith
a deletion of 897 bp including the last 386 nucleotides of intron 18,
exon 19 (168 bp), and the first 343 bp of intron 19
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“aactcctgacctcaggtgatc” sequences within introns 18 and
19, generating the large deletion (Fig. 2c).
The mechanism involving unequal homologous recom-
bination between highly similar Alu elements has been
described as contributing to several genetic diseases
(Deininger and Batzer 1999), such as ornithine trans-
carbamylase deficiency (OTCD) (Quental et al. 2009),
Von Hippel-Lindau disease (VHL) (Franke et al. 2009),
Kindler syndrome (Has et al. 2006) and maple syrup urine
disease (Quental et al. 2008).
This distribution of Alu sequences within GNPTAB,
indicates that homologous recombination events mediated
by similar Alu elements might involve introns 18 and 19
and the 30UTR, increasing the risk of generating gross
defective alleles at the gene, some of which may remain
unidentified. We can hypothesise that at least some ML II
patients from whom no RNA samples were available and,
in whom only one mutant allele has previously been found
(Encarnação et al. 2009; Tappino et al. 2009; Otomo et al.
2009; Zarghooni and Dittakavi 2009), might be compound
heterozygous for large deletions caused by Alu-mediated
mechanisms. The confirmation of that status would be of
obvious implications in genetic counselling and prenatal
diagnosis, but in which regards to the partially characterised
patients from our series (Encarnação et al. 2009), RNA
samples were available for testing and no gross deletions
were found in either of them. Another important point that
deserves attention is the fact that patients who have already
been classified as homozygous for other GNPTAB muta-
tions may be misclassified if that mutation happens to occur
in a region where one of the alleles carries a gross deletion.
Such may be of great importance for a correct establish-
ment of genotype–phenotype correlations.
Finally, to address the impact of the novel deletion upon
RNA processing, RT_PCR of the GNPTAB cDNA region
encompassing exons 17–21 (734 bp) revealed the presence
of three abnormal transcripts (Fig. 3a): one without exons
19 and 20 (Fig. 3b); transcript 1; another with the loss of
exon 19 alone (Fig. 3b; transcript 2), and a third in which
exon 19 was substituted by a pseudoexon inclusion
consisting of a 62 bp fragment from intron 18 (Fig. 3b;
transcript 3). At a protein level, all three transcripts give
rise to aberrant truncated proteins: transcript 1 (Fig. 3) leads
to the substitution of an arginine by a serine at position
1145, with a consequent frameshift that results in the
introduction of a novel amino acid at position 1146 and of
a PTC at position 1147 (p.Arg1145Serfs*2); transcript
2 leads to the formation of a mutant protein with
less 56 amino acids between positions 1146 and 1201
(p.Lys1146_Trp1201del); transcript 3 (Fig. 3) also leads to
a b
Fig. 3 Agarose gel showing the GNPTAB transcripts observed in the
affected individual together with schematic views of each transcript’s
constitution. (a) Agarose gel showing the GNPTAB transcripts
observed in the affected individual. P patient, C control, M marker
(GeneRuller™ DNA Ladder 100–10,000 bp, Fermentas). (b) Sche-
matic representation of the three abnormal transcripts. The first
transcript presented loss of exons 19 and 20 (b1). The second
transcript presented the loss of exon 19 alone (b2) and the third one
instead of exon 19 had an inclusion of 62 bp of the Alu-Sz element of
intron 18 (b3). (c) Schematic representation of the potential 50ss of the
pseudoexon showing its correspondence to one of the sequences
referred to by Sorek et al. (2004) as necessary for the creation of
alternatively spliced Alu exons
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a frameshift after the substitution Arg1145Ser with intro-
duction of 15 novel amino acids followed by a PTC
(p.Arg1145Serfs*16).
The finding that this 62 bp fragment corresponded to the
majority of the Alu-Sz element integrated in intron 18
(Fig. 3c), is quite curious since there are several recent
studies in which pseudoexons were characterised as Alu or
LINE elements (Knebelmann et al. 1995; Meili et al. 2009;
Mitchell et al. 1991; Pérez et al. 2009; Vervoort et al.
1998), as well as with recent estimates indicating that up to
5% of human alternative exons could be derived from Alu
sequences (Sorek et al. 2004; Tazi et al. 2009; Wood et al.
2007). With this in mind, we looked for Alu sequences
within GNPTAB exons, but no repetitive sequences were
found in any of them, indicating that exonization was not
an evolutionary mechanism at the GNPTAB gene. Accord-
ing to the current state of knowledge, exonization of Alu
sequences depends almost solely on the sequence composi-
tion of the potential 30 and 50 splice sites. Alus containing
the 30ss sequences described by Lev-Maor et al. (2003) or
the 50ss sequences reported by Sorek et al. (2004), are
highly scored to become alternatively spliced exons. On
these grounds, after analysing within intron 18 the flanking
sequences of both potential splice sites of the Alu-Sz
element, we verified that although the 30ss sequence was
different from that described by Lev-Maor et al. (2003), the
residues of intron 18 that are flanking the potential 50ss
corresponded to one of the sequences referred to by Sorek
et al. (2004) as necessary for the creation of alternatively
spliced Alu exons (Fig. 3c). Consistently, the MaxEnt
prediction of scores for the splice site junctions pointed
towards an activation of a downstream cryptic splice site in
intron 18 (50ss ¼ 9.70) to produce the transcript with the
pseudoexon inclusion (Fig. 3b; transcript 3). Taking this
data into account, it seems that the novel deletion c.3435-
386_3602 + 343del897, here reported activates a cryptical
splice site on the Alu-Sz element in such a way that it is
recognised as an exon.
Altogether, these results clearly demonstrate that this
deletion causes a serious aberration in the splicing pattern
of the mutant pre mRNA GNPTAB, with three mutant
transcripts being formed and at the protein level, which
would have gone unnoticed if only simple gDNA analyses
had been carried out.
Conclusion
In this study, we present the first report of a large deletion
in the GNPTAB gene (c.3435-386_3602 + 343del897). The
mutation was found in a severely affected ML II patient with
prenatal onset, severe skeletal changes and hyperparathy-
roidism and causes homozygous loss of exon 19 and some of
its surrounding intronic regions. Given the presence of two
highly homologous Alu elements in exons 18 and 19, the
deletion was probably caused by a process of unequal
homologous recombination. Processing of the mutant pre
mRNA GNPTAB causes production of three abnormal
transcripts: one without exon 19 (p.Lys1146_Trp1201del);
another with an additional loss of exon 20 (p.Arg1145-
Serfs*2) and a third in which exon 19 was substituted by a
pseudoexon inclusion consisting of a 62 bp fragment from
intron 18 (p.Arg1145Serfs*16). It is important to take into
account the possible existence of such large deletions when
performing molecular screenings of the GNPTAB gene,
being aware that when present in heterozygosity, they might
easily escape detection through DNA genomic analyses.
Without direct cDNA examination, this kind of mutation can
remain unidentified.
From the results obtained, we recommend that ML II a/b
and ML III a/b cases with only one mutant allele detected
at direct sequencing should be further examined for the
presence of large heterozygous deletions to strengthen the
accuracy of genetic counselling and prenatal diagnosis in
the families at risk.
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One Sentence Take-Home Message
First large genomic deletion in the GNPTAB gene.
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